Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-09T15:38:40.431Z Has data issue: false hasContentIssue false

Evaluation of the effects of levobupivacaine on clotting and fibrinolysis using thromboelastography

Published online by Cambridge University Press:  16 August 2006

S. A. Leonard
Affiliation:
Department of Anaesthesia and Intensive Care Medicine, Cork University Hospital and University College Cork, Crumlin, Dublin, Ireland
M. Walsh
Affiliation:
Department of Anaesthesia, Our Lady’s Hospital for Sick Children, Crumlin, Dublin, Ireland
A. Lydon
Affiliation:
Department of Anaesthesia, St Vincents’ Hospital, Elm Park, Dublin, Ireland
B. O'Hare
Affiliation:
Department of Anaesthesia, Our Lady’s Hospital for Sick Children, Crumlin, Dublin, Ireland
G. D. Shorten
Affiliation:
Department of Anaesthesia and Intensive Care Medicine, Cork University Hospital and University College Cork, Crumlin, Dublin, Ireland
Get access

Abstract

Amide local anaesthetics inhibit platelet function. We hypothesized that residual anaesthetic in the epidural space could decrease efficacy of an epidural blood patch in preventing postdural puncture headache. Levobupivacaine has recently been approved for epidural anaesthesia. Its effects on coagulation have not previously been studied. The aim of this study was to determine the effects of levobupivacaine on clotting using thromboelastography. Ten ASA Class I volunteers were studied. Venous blood samples were analysed using a Haemoscope 2000D TEG analyser. Whole blood, a 50% saline control and two levobupivacaine solutions (2.5 mg mL−1 and 2.5 μg mL−1 in blood) were compared. The former reproduces that produced in the epidural space by blood (20 mL for an epidural blood patch) and levobupivacaine 0.5% (20 mL). The latter approximates plasma concentrations following epidural injection of levobupivacaine 0.5% (20 mL). P < 0.05 was considered significant. Maximum amplitude (MA), a measure of clot strength, is decreased by levobupivacaine 2.5 mg mL−1. Levobupivacaine 2.5 mg mL−1 decreases clot strength and may reduce efficacy of a prophylactic epidural blood patch.

Type
Original Article
Copyright
2000 European Society of Anaesthesiology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)